Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2026

Antidilutive Securities Excluded from Computation of Earnings Per Share

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive are as follows:


	June 30, 2026	June 30, 2025
	(shares)	(shares)
Warrants to purchase shares of common stock	1,550,000	9,704,430
Options to purchase shares of common stock	7,033,681	7,541,818
Restricted stock units	518,158	496,520
Shares of common stock issuable upon conversion of convertible notes payable – related party	7,937,397	7,327,374
Shares of common stock issuable upon conversion of convertible line of credit – related party	34,191,381	29,621,834
Shares of common stock issuable upon conversion of preferred stock	490,840	495,007
	51,721,456	55,186,983